Skip to Content

Book Series

Chapman & Hall/CRC Biostatistics Series

Series Editor: Shein-Chung Chow, Karl E. Peace, Jen-pei Liu, Byron Jones, Bruce W. Turnbull

New and Published Books

1-10 of 72 results in Chapman & Hall/CRC Biostatistics Series
  1. Mixed Effects Models for the Population Approach

    Models, Tasks, Methods and Tools

    By Marc Lavielle

    Series: Chapman & Hall/CRC Biostatistics Series

    Wide-Ranging Coverage of Parametric Modeling in Linear and Nonlinear Mixed Effects ModelsMixed Effects Models for the Population Approach: Models, Tasks, Methods and Tools presents a rigorous framework for describing, implementing, and using mixed effects models. With these models, readers can...

    Published July 13th 2014 by Chapman and Hall/CRC

  2. Clinical and Statistical Considerations in Personalized Medicine

    Edited by Claudio Carini, Sandeep M Menon, Mark Chang

    Series: Chapman & Hall/CRC Biostatistics Series

    The Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances related to biomarkers and their translation into clinical development. Leading clinicians, biostatisticians, regulators,...

    Published March 26th 2014 by Chapman and Hall/CRC

  3. Patient-Reported Outcomes

    Measurement, Implementation and Interpretation

    By Joseph C. Cappelleri, Kelly H. Zou, Andrew G. Bushmakin, Jose Ma. J. Alvir, Demissie Alemayehu, Tara Symonds

    Series: Chapman & Hall/CRC Biostatistics Series

    Advancing the development, validation, and use of patient-reported outcome (PRO) measures, Patient-Reported Outcomes: Measurement, Implementation and Interpretation helps readers develop and enrich their understanding of PRO methodology, particularly from a quantitative perspective. Designed for...

    Published December 19th 2013 by Chapman and Hall/CRC

  4. Benefit-Risk Assessment in Pharmaceutical Research and Development

    Edited by Andreas Sashegyi, James Felli, Rebecca Noel

    Series: Chapman & Hall/CRC Biostatistics Series

    Many practitioners in the pharmaceutical industry are still largely unfamiliar with benefit-risk assessment, despite its growing prominence in drug development and commercialization. Helping to alleviate this knowledge gap, Benefit-Risk Assessment in Pharmaceutical Research and Development provides...

    Published November 26th 2013 by Chapman and Hall/CRC

  5. Statistical Analysis of Human Growth and Development

    By Yin Bun Cheung

    Series: Chapman & Hall/CRC Biostatistics Series

    Statistical Analysis of Human Growth and Development is an accessible and practical guide to a wide range of basic and advanced statistical methods that are useful for studying human growth and development. Designed for nonstatisticians and statisticians new to the analysis of growth and...

    Published October 27th 2013 by Chapman and Hall/CRC

  6. Theory of Drug Development

    By Eric B. Holmgren

    Series: Chapman & Hall/CRC Biostatistics Series

    Theory of Drug Development presents a formal quantitative framework for understanding drug development that goes beyond simply describing the properties of the statistics in individual studies. It examines the drug development process from the perspectives of drug companies and regulatory agencies....

    Published October 23rd 2013 by Chapman and Hall/CRC

  7. Bayesian Methods in Epidemiology

    By Lyle D. Broemeling

    Series: Chapman & Hall/CRC Biostatistics Series

    Written by a biostatistics expert with over 20 years of experience in the field, Bayesian Methods in Epidemiology presents statistical methods used in epidemiology from a Bayesian viewpoint. It employs the software package WinBUGS to carry out the analyses and offers the code in the text and for...

    Published August 12th 2013 by Chapman and Hall/CRC